<SEC-DOCUMENT>9999999997-24-004217-index.html : 20241211
<SEC-HEADER>9999999997-24-004217.hdr.sgml : 20241211
<ACCEPTANCE-DATETIME>20241030162158
ACCESSION NUMBER:		9999999997-24-004217
CONFORMED SUBMISSION TYPE:	SEC STAFF LETTER
CATEGORY:             	REDACTED EXHIBIT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241028
ACTION DATE:               	20241028
RECEIVED DATE:           	20241030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Telix Pharmaceuticals Ltd
		CENTRAL INDEX KEY:			0002007191
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SEC STAFF LETTER

	BUSINESS ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
		BUSINESS PHONE:		61 3 9093 3855

	MAIL ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
</SEC-HEADER>
<DOCUMENT>
<TYPE>REDACTED EXHIBIT
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
Document 1 - file: filename1.pdf

</DOCUMENT>
</SEC-DOCUMENT>